{"id":"W1870006248","doi":"","title":"An update on the long-term safety experience of ustekinumab: results from the psoriasis clinical development program with up to four years of follow-up.","year":2012,"lang":"en","type":"article","venue":"PubMed","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":74,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Ustekinumab; Discontinuation; Mace; Adverse effect; Psoriasis; Stroke (engine); Internal medicine; Myocardial infarction; Randomized controlled trial; Dermatology; Disease; Infliximab; Percutaneous coronary intervention","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01428716,0.0005618262,0.001106587,0.001532795,0.0002565193,0.001592457,0.000968624,0.0009736008,0.00189029],"category_scores_gemma":[0.01393265,0.000246494,0.001284224,0.002281402,0.0002295741,0.001440592,0.0005840774,0.001596189,0.0007145154],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007893332,"about_ca_system_score_gemma":0.00174056,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001506664,"about_ca_topic_score_gemma":0.001807544,"domain_scores_codex":[0.9952828,0.001452107,0.0009387381,0.0002452346,0.001903662,0.0001774039],"domain_scores_gemma":[0.9677711,0.01149967,0.007720851,0.0009132469,0.01068576,0.001409404],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003920815,0.0004494493,0.03329908,0.003247271,0.0007033581,0.0002405314,0.0002406027,0.0004713046,0.002354214,0.0003327638,0.03716633,0.9175743],"study_design_scores_gemma":[0.002225864,0.009919672,0.3951469,0.00538952,0.006767939,0.006586117,0.0004029752,0.001319914,0.007409457,0.0008374594,0.5638409,0.0001533039],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.146414,0.7895948,0.009184738,0.01503933,0.001557218,0.0005864331,0.01709536,0.0005130555,0.02001503],"genre_scores_gemma":[0.4907078,0.4304807,0.01914601,0.0106307,0.003901512,0.001038783,0.03635798,0.0002251965,0.007511401],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01428716,"threshold_uncertainty_score":0.0755586,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.064260563350052,"score_gpt":0.2900492829499989,"score_spread":0.225788719599947,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}